IRIS
SVEGLIATI BARONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.906
EU - Europa 3.527
AS - Asia 2.529
SA - Sud America 755
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
AN - Antartide 1
Totale 11.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.807
RU - Federazione Russa 1.119
SG - Singapore 769
BR - Brasile 594
VN - Vietnam 584
CN - Cina 437
UA - Ucraina 430
IT - Italia 416
DE - Germania 299
SE - Svezia 292
IE - Irlanda 241
TR - Turchia 212
HK - Hong Kong 196
FR - Francia 184
DK - Danimarca 155
FI - Finlandia 135
GB - Regno Unito 108
KR - Corea 87
AR - Argentina 54
CA - Canada 54
IN - India 51
ZA - Sudafrica 33
BD - Bangladesh 32
CI - Costa d'Avorio 32
PL - Polonia 32
EC - Ecuador 31
MA - Marocco 28
MX - Messico 27
ID - Indonesia 25
CO - Colombia 22
IQ - Iraq 21
ES - Italia 19
AT - Austria 18
BE - Belgio 18
NL - Olanda 18
PK - Pakistan 18
JP - Giappone 15
VE - Venezuela 14
TN - Tunisia 13
LT - Lituania 12
PY - Paraguay 12
CL - Cile 11
EG - Egitto 8
SA - Arabia Saudita 8
UY - Uruguay 8
UZ - Uzbekistan 8
AU - Australia 6
EU - Europa 6
JO - Giordania 6
KZ - Kazakistan 6
MY - Malesia 6
OM - Oman 6
PH - Filippine 6
DZ - Algeria 5
NP - Nepal 5
PS - Palestinian Territory 5
RS - Serbia 5
LB - Libano 4
PE - Perù 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
MD - Moldavia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CZ - Repubblica Ceca 2
GA - Gabon 2
HR - Croazia 2
JM - Giamaica 2
NI - Nicaragua 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BH - Bahrain 1
CG - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
MW - Malawi 1
Totale 11.859
Salva come PNG Salva come JPEG
Città #
Ashburn 687
Chandler 604
Singapore 450
Jacksonville 434
Boardman 239
Dublin 237
Ho Chi Minh City 207
San Jose 195
Dallas 193
Hong Kong 189
Fairfield 183
New York 153
Beijing 146
Wilmington 137
Hanoi 122
The Dalles 116
Lawrence 93
Princeton 93
Centro 87
San Mateo 87
Los Angeles 86
Woodbridge 86
Moscow 85
Des Moines 81
Lauterbourg 81
Ann Arbor 79
Houston 77
São Paulo 67
Munich 61
Seattle 58
Hefei 55
Ancona 49
Cambridge 49
Milan 49
Buffalo 45
Da Nang 39
Helsinki 36
San Diego 33
Turin 32
Abidjan 31
Orem 30
London 28
Warsaw 27
Council Bluffs 23
Nuremberg 21
Turku 21
Haiphong 20
Rio de Janeiro 20
Montreal 19
Santa Clara 18
Chennai 17
Johannesburg 17
Brussels 16
Chicago 16
Guangzhou 15
San Francisco 15
Stockholm 14
Frankfurt am Main 13
Poplar 13
Washington 13
Denver 12
Phoenix 12
Shanghai 12
Atlanta 11
Belo Horizonte 11
Boston 11
Guayaquil 11
Izmir 11
Marche 11
Mexico City 11
Pune 11
Brooklyn 10
Goiânia 10
Porto Alegre 9
Tokyo 9
Toronto 9
Wuhan 9
Amsterdam 8
Brasília 8
Bắc Ninh 8
Curitiba 8
Guarulhos 8
Hải Dương 8
Juneau 8
Miano 8
Monte San Pietrangeli 8
Montevideo 8
Redmond 8
Ankara 7
Buenos Aires 7
Charlotte 7
Rome 7
Tashkent 7
Amman 6
Biên Hòa 6
Bắc Giang 6
Caxias do Sul 6
Columbus 6
Itaquaquecetuba 6
Jesi 6
Totale 6.552
Salva come PNG Salva come JPEG
Nome #
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 807
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 190
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 187
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 186
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 182
Metabolomic profile of systemic sclerosis patients 173
c-MYB transactivates the alpha 2(I) collagen gene. 163
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 159
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 159
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 153
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality 152
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 149
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 149
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 148
Bone formation by distraction clinical and structural studies 147
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 146
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 146
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 145
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 141
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 132
Agonistic antibodies in systemic sclerosis 132
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 131
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 129
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 127
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 127
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 127
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 126
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 126
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 125
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 124
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 123
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 123
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 122
Pathogenic autoantibodies in systemic sclerosis 121
Stimulatory autoantibodies against PDGF receptors in Scleroderma 121
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 121
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 120
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 119
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 119
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 118
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 118
Dietary restriction affects antioxidant levels in rat liver mitochondria during ageing 117
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 117
Putative functional pathogenic autoantibodies in systemic sclerosis 117
Association between TNF-α, cortisol levels, and exposure to PM10 and PM2.5: a pilot study 116
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 116
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 116
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 115
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 114
Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the ageing rat. 113
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 113
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 111
Solid monounsaturated diet lowers LDL unsaturation trait and oxidisability in hypercholesterolemic (type IIb) patients 110
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 109
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 109
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 109
Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvemen 108
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 107
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 105
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 105
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 105
Dietary restriction affects antioxidant levels in rat liver mitochondria diuring aging 105
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 104
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 104
Coenzyme Q homologs and Vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the aging rat 104
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 104
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 101
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 101
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 100
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 100
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 99
The Wnt signalling inhibitor gene, WIF-1, expression is downregulated in fibroblasts derived from systemic sclerosis patients by a persistent oxidative stress 98
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 96
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 96
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 96
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 95
Biological effects of serum immunoglobulins from scleroderma patients on human pulmonary artery smooth muscle cells. Role of NOX4 and ROS 94
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 94
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 93
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 91
Lipid raft colocalization of PDGFR-NADPH complex and receptor integrity are important for the activation of the intracellular signaling by scleroderma IgG in normal human fibroblasts 89
Rituximab for the treatment of cutaneous involvement in systemic sclerosis. evidence for a pathogenetic role of B-CELLS 89
Unbalance between Ha- and Ki-Ras is responsible for scleroderma fibroblast activation 89
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes. 88
The important role of molecular analyses to evaluate the efficacy of Rituximab treatment in a patient affected by severe multineuropathy in mixed cryoglobulinemia disease. 87
STIMULATORY AUTOANTIBODIES AGAINST PDGF RECEPTOR IN A LARGE COHORT OF ITALIAN SCLERODERMA PATIENTS 85
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 83
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of free radical generation through the NADPH oxidase complex pathway 82
Reactive oxygen species are required for manteinance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. 82
Stimulatory autoantibodies to the PDGF receptor in scleroderma (Correspondence) 80
Intracellular free radical production by peripheral blood T lymphocytes from patients with Systemic Sclerosis: role of NADPH oxidase and ras 80
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 80
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 79
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 79
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 74
New insights into the role of oxidative stress in scleroderma fibrosis. 65
Dietary olive oil affects LDL peroxidability in hypercholesterolemic (IIB) patients 58
Expression profile and regulation of NOX proteins in Systemic Sclerosis 56
null 24
Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study 15
Totale 11.984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.318
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022614 36 169 9 32 11 24 14 56 42 32 51 138
2022/20231.530 134 188 110 161 138 202 6 98 366 9 82 36
2023/2024752 140 29 40 125 127 170 9 12 0 15 6 79
2024/20251.553 149 145 68 12 93 18 174 43 353 103 168 227
2025/20265.099 379 491 235 502 467 349 677 450 958 306 119 166
Totale 11.995